Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing testicular cancer therapy: Survivorship perspectives on reducing late toxicities without compromising outcomes.

Urologic oncology·2026
Same author

Persistent suicide risk in survivors of testicular cancer: A population-based cohort study.

Urologic oncology·2026
Same author

Mitomycin Gel for the Pyelocaliceal System in Patients With Urinary Diversion: First Reported Cases and Operative Technique.

Case reports in urology·2026
Same author

Deep learning-based detection and segmentation of osseous metastatic prostate cancer lesions on computed tomography.

European journal of radiology artificial intelligence·2026
Same author

Mental Health Burden of a Testicular Cancer Diagnosis: Insights From a Large Claims Database.

Urology·2026
Same author

Cu-Enhanced Bottlebrush Composite Polymer Electrolytes for Superior Mechanical and Electrochemical Performance.

ACS applied energy materials·2025

Related Experiment Video

Updated: May 5, 2026

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

13.6K

Circulating tumor cells in prostate cancer.

Brian Hu1, Holly Rochefort, Amir Goldkorn

  • 1Institute of Urology, University of Southern California, 1441 Eastlake Avenue, Suite 7416, Los Angeles, CA 90033, USA. agoldkor@usc.edu.

Cancers
|December 6, 2013
PubMed
Summary

Circulating tumor cells (CTCs) offer a non-invasive liquid biopsy for prostate cancer. Advanced molecular analysis of CTCs provides insights into tumor changes, aiding in disease management.

More Related Videos

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

8.4K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

13.9K

Related Experiment Videos

Last Updated: May 5, 2026

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

13.6K
In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

8.4K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

13.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Diagnostics

Background:

  • Circulating tumor cells (CTCs) provide a non-invasive method to analyze tumors.
  • CTC enumeration is an FDA-cleared prognostic tool for advanced prostate cancer.
  • Current research focuses on molecular characterization of CTCs for deeper insights.

Purpose of the Study:

  • To review studies on CTCs in advanced and localized prostate cancer.
  • To highlight advancements and challenges in CTC analysis.
  • To discuss the implications of CTCs for prostate cancer management.

Main Methods:

  • Review of existing literature on CTC studies in prostate cancer.
  • Analysis of methodologies for CTC enumeration and molecular characterization.
  • Evaluation of clinical applications and prognostic value of CTCs.

Main Results:

  • CTC enumeration is validated for prognosis and monitoring in advanced prostate cancer.
  • Molecular characterization of CTCs offers a 'liquid biopsy' approach.
  • Various CTC analysis techniques present both opportunities and challenges.

Conclusions:

  • CTCs are valuable for understanding tumor heterogeneity and evolution.
  • Further research is needed to overcome challenges in CTC analysis.
  • CTCs hold significant potential for advancing prostate cancer diagnosis and treatment.